HN-1 Taxane (Tapestry Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHN-1 Taxane (Tapestry Pharmaceuticals)

Drug Alias NameHN-1 peptide linked cytoxin (NaPro)head & neck cancer therapeutic (NaPro)head & neck cancer therapeutic (Tapestry)HN-1 peptide linked cytoxin (Tapestry)TPI-284

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionCell cycle inhibitorsMicrotubule stabilizer

TargetsUpdating

Therapy Area/IndicationsHead and Neck NeoplasmsCarcinoma, Squamous Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTapestry Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTapestry Pharmaceuticals

Active IndicationsN/A

Inactive IndicationsHead and Neck NeoplasmsCarcinoma, Squamous Cell

Other Information

ATC CodeN/A